BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19670456)

  • 1. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
    Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
    Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
    Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
    Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved estimates of cancer-specific survival rates from population-based data.
    Howlader N; Ries LA; Mariotto AB; Reichman ME; Ruhl J; Cronin KA
    J Natl Cancer Inst; 2010 Oct; 102(20):1584-98. PubMed ID: 20937991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study.
    Li S; Liu F; Chen K; Rao N; Xie Y; Su F; Zhu L
    Medicine (Baltimore); 2016 Apr; 95(14):e3254. PubMed ID: 27057872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncancer deaths in white adult cancer patients.
    Brown BW; Brauner C; Minnotte MC
    J Natl Cancer Inst; 1993 Jun; 85(12):979-87. PubMed ID: 8496983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
    Roberts MC; Miller DP; Shak S; Petkov VI
    Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
    Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
    JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life expectancy of colon, breast, and testicular cancer patients: an analysis of US-SEER population-based data.
    Capocaccia R; Gatta G; Dal Maso L
    Ann Oncol; 2015 Jun; 26(6):1263-1268. PubMed ID: 25735314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished survival in patients with inner versus outer quadrant breast cancers.
    Gaffney DK; Tsodikov A; Wiggins CL
    J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
    Hu CY; Xing Y; Cormier JN; Chang GJ
    Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined.
    Polednak AP
    Ann Surg; 2003 Feb; 237(2):163-7. PubMed ID: 12560772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
    Rose BS; Jiang W; Punglia RS
    Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of implant vs. tissue reconstruction on cancer specific survival varies by axillary lymph node status in breast cancer patients.
    Ouyang Q; Zhu L; Chen K; Su F
    PLoS One; 2015; 10(2):e0118161. PubMed ID: 25692294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
    Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
    J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study.
    Ye JC; Yan W; Christos P; Nori D; Chao KS; Ravi A
    Clin Breast Cancer; 2015 Feb; 15(1):54-9. PubMed ID: 25223278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
    Cronin KA; Feuer EJ
    Stat Med; 2000 Jul; 19(13):1729-40. PubMed ID: 10861774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lifetime risk of developing breast cancer.
    Feuer EJ; Wun LM; Boring CC; Flanders WD; Timmel MJ; Tong T
    J Natl Cancer Inst; 1993 Jun; 85(11):892-7. PubMed ID: 8492317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.